Hemofília: nyitott vizsgálatok itt: Belgium
9 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Leuven, Sint-Lambrechts-Woluwe
- Age
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604EU 2025-522435-33-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- Where
- Brussels, Sint-Lambrechts-Woluwe
- Age
- 1 év to 11 év
- People
- 85 worldwide
- Run by
- Sanofi
See details and how to joinNCT07285460EU 2025-521858-42-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- Where
- Leuven
- Age
- 138 hónap to 206 hónap
- People
- 20 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07080905EU 2023-505805-18-00Regiszter frissítve: 2026-10-20
1. fázisToborozTrial-stage medicine
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Where
- Sint-Lambrechts-Woluwe
- Age
- 18 év to 64 év
- People
- 30 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07220564EU 2025-520490-38-00Regiszter frissítve: 2026-09-18
No phaseCsak meghívásosResearch participation
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
- Where
- Brussels, Edegem, Leuven
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03745924Regiszter frissítve: 2026-06-12
No phaseToborozResearch participation
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Brussels
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978Regiszter frissítve: 2026-06-02
4. fázisCsak meghívásosResearch participation
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
- Where
- Leuven
- Age
- 18 év and over
- People
- 172 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT05768386EU 2023-507749-27-00Regiszter frissítve: 2026-01-12
No phaseToborozResearch participation
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Leuven
- People
- 4000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119Regiszter frissítve: 2025-09-16
2/3. fázisCsak meghívásosResearch participation
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
- Where
- Leuven, Sint-Lambrechts-Woluwe
- Age
- 18 év and over
- People
- 56 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05962398EU 2023-503765-37-00Regiszter frissítve: 2025-07-18
Minden vizsgálat (Hemofília) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.